Efficacy and Safety of Moxonidine in Indian Patients

Phase 3CompletedNCT00160277

Solvay Pharmaceuticals100 enrolled

Overview

The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

100

Conditions

Hypertension

Interventions

MoxonidineDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: Hypertension Exclusion Criteria: Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina

Locations (3)

Site 1

Jubillee Hills Hyderabad, India

Site 2

Mangalore, India

Site 3

New Delhi, India

Outcomes

Primary Outcomes

Systolic blood pressure reduction

Secondary Outcomes

Piggy-back pharmacoeconomic evaluation; Safety and tolerability

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.